Larisma, Rosalie C.

HRN: 29-06-72  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2026
CEFTRIAXONE 1G (VIAL)
05/30/2026
06/05/2026
IV
2g
OD
HAP, Intubated
Checking Initial Appropriateness 
05/30/2026
MUPIROCIN 2%, 15G (TUBE)
05/30/2026
06/05/2026
TOPICAL
2%
BID
Ulcer
Checking Initial Appropriateness 
05/31/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/31/2026
06/07/2026
IV
4.5
Q6
CAP HR
Checking Initial Appropriateness 
06/01/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/01/2026
06/08/2026
IVTT
900mg
Q8H
CELLULITIS
Checking Initial Appropriateness 
06/01/2026
CEFTRIAXONE 1G (VIAL)
06/01/2026
06/08/2026
IV
2g
OD
HAP, Cellulitis
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: